At 1 year , however , cumulative rates of first new or worsening angina from adverse event reporting were lower ( 72 patients [ 22 % ] in the bioresorbable scaffold group vs 50 [ 30 % ] in the metallic stent group , p = 0.04 ) , whereas performance during maximum exercise and angina status by SAQ were similar .